Scaling-up integrated type-2 diabetes and hypertension care in Cambodia: what are the barriers to health system performance?

Cambodia barriers health system health system dynamic hypertension scale-up type-2 diabetes

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 03 01 2023
accepted: 11 05 2023
medline: 20 6 2023
pubmed: 19 6 2023
entrez: 19 6 2023
Statut: epublish

Résumé

Non-communicable diseases (NCDs) such as type-2 diabetes (T2D) and hypertension (HTN) pose a massive burden on health systems, especially in low- and middle-income countries. In Cambodia, to tackle this issue, the government and partners have introduced several limited interventions to ensure service availability. However, scaling-up these health system interventions is needed to ensure universal supply and access to NCDs care for Cambodians. This study aims to explore the macro-level barriers of the health system that have impeded the scaling-up of integrated T2D and HTN care in Cambodia. Using qualitative research design comprised an articulation between (i) semi-structured interviews (33 key informant interviews and 14 focus group discussions), (ii) a review of the National Strategic Plan and policy documents related to NCD/T2D/HTN care using qualitative document analysis, and (iii) direct field observation to gain an overview into health system factors. We used a health system dynamic framework to map macro-level barriers to the health system elements in thematic content analysis. Scaling-up the T2D and HTN care was impeded by the major macro-level barriers of the health system including weak leadership and governance, resource constraints (dominantly financial resources), and poor arrangement of the current health service delivery. These were the result of the complex interaction of the health system elements including the absence of a roadmap as a strategic plan for the NCD approach in health service delivery, limited government investment in NCDs, lack of collaboration between key actors, limited competency of healthcare workers due to insufficient training and lack of supporting resources, mis-match the demand and supply of medicine, and absence of local data to generate evidence-based for the decision-making. The health system plays a vital role in responding to the disease burden through the implementation and scale-up of health system interventions. To respond to barriers across the entire health system and the inter-relatedness of each element, and to gear toward the outcome and goals of the health system for a (cost-)effective scale-up of integrated T2D and HTN care, key strategic priorities are: (1) Cultivating leadership and governance, (2) Revitalizing the health service delivery, (3) Addressing resource constraints, and (4) Renovating the social protection schemes.

Sections du résumé

Background
Non-communicable diseases (NCDs) such as type-2 diabetes (T2D) and hypertension (HTN) pose a massive burden on health systems, especially in low- and middle-income countries. In Cambodia, to tackle this issue, the government and partners have introduced several limited interventions to ensure service availability. However, scaling-up these health system interventions is needed to ensure universal supply and access to NCDs care for Cambodians. This study aims to explore the macro-level barriers of the health system that have impeded the scaling-up of integrated T2D and HTN care in Cambodia.
Methods
Using qualitative research design comprised an articulation between (i) semi-structured interviews (33 key informant interviews and 14 focus group discussions), (ii) a review of the National Strategic Plan and policy documents related to NCD/T2D/HTN care using qualitative document analysis, and (iii) direct field observation to gain an overview into health system factors. We used a health system dynamic framework to map macro-level barriers to the health system elements in thematic content analysis.
Results
Scaling-up the T2D and HTN care was impeded by the major macro-level barriers of the health system including weak leadership and governance, resource constraints (dominantly financial resources), and poor arrangement of the current health service delivery. These were the result of the complex interaction of the health system elements including the absence of a roadmap as a strategic plan for the NCD approach in health service delivery, limited government investment in NCDs, lack of collaboration between key actors, limited competency of healthcare workers due to insufficient training and lack of supporting resources, mis-match the demand and supply of medicine, and absence of local data to generate evidence-based for the decision-making.
Conclusion
The health system plays a vital role in responding to the disease burden through the implementation and scale-up of health system interventions. To respond to barriers across the entire health system and the inter-relatedness of each element, and to gear toward the outcome and goals of the health system for a (cost-)effective scale-up of integrated T2D and HTN care, key strategic priorities are: (1) Cultivating leadership and governance, (2) Revitalizing the health service delivery, (3) Addressing resource constraints, and (4) Renovating the social protection schemes.

Identifiants

pubmed: 37333565
doi: 10.3389/fpubh.2023.1136520
pmc: PMC10272385
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1136520

Informations de copyright

Copyright © 2023 Chham, Van Olmen, Van Damme, Chhim, Buffel, Wouters and Ir.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Lancet. 2018 Mar 24;391(10126):1224-1236
pubmed: 29108723
PLoS One. 2022 Jul 28;17(7):e0272071
pubmed: 35901114
Diabetes Metab Syndr Obes. 2017 Jun 22;10:247-263
pubmed: 28790858
PLoS One. 2016 Jan 27;11(1):e0146147
pubmed: 26815916
Health Res Policy Syst. 2016 Mar 14;14:18
pubmed: 26975311
Lancet Healthy Longev. 2021 Jun;2(6):e340-e351
pubmed: 35211689
Qual Life Res. 2021 Dec;30(12):3343-3357
pubmed: 33651278
PLoS Med. 2020 Nov 12;17(11):e1003434
pubmed: 33180775
BMC Health Serv Res. 2022 Jun 29;22(1):838
pubmed: 35768805
Lancet. 2022 Mar 26;399(10331):1266-1278
pubmed: 35339227
Glob Heart. 2012 Mar;7(1):53-60
pubmed: 25691168
Global Health. 2014 Jun 13;10:49
pubmed: 24927745
PLoS One. 2015 Apr 13;10(4):e0120941
pubmed: 25875825
BMC Health Serv Res. 2019 Oct 15;19(1):693
pubmed: 31615529
PLoS One. 2014 Sep 04;9(9):e106522
pubmed: 25188582
Int J Public Health. 2017 Sep;62(7):747-753
pubmed: 27942746
Health Policy Plan. 2020 Mar 1;35(2):219-234
pubmed: 31722382
BMJ Glob Health. 2019 Nov 13;4(6):e001679
pubmed: 31798986
Bull World Health Organ. 2009 Jul;87(7):560-4
pubmed: 19649372
BMC Health Serv Res. 2019 Jan 18;19(1):44
pubmed: 30658641
BMC Public Health. 2019 Nov 21;19(1):1542
pubmed: 31752801
Lancet. 2019 Aug 24;394(10199):652-662
pubmed: 31327566
BMC Public Health. 2012 Sep 12;12:774
pubmed: 22971107
Lancet. 2017 Jun 3;389(10085):2239-2251
pubmed: 28190580
Global Health. 2012 May 29;8:11
pubmed: 22643120
Lancet. 2013 Feb 23;381(9867):680-9
pubmed: 23410612
Health Policy. 2015 Sep;119(9):1164-75
pubmed: 26271138
JMIR Res Protoc. 2022 Sep 2;11(9):e36747
pubmed: 36053576
Global Health. 2015 Nov 10;11:43
pubmed: 26555199
Health Res Policy Syst. 2016 Mar 17;14:20
pubmed: 26983405
PLOS Glob Public Health. 2021 Oct 13;1(10):e0000026
pubmed: 36962081
BMC Health Serv Res. 2017 Aug 22;17(1):575
pubmed: 28830542
Glob Health Action. 2020 Dec 31;13(1):1824382
pubmed: 33373278
Lancet. 2008 Sep 13;372(9642):940-9
pubmed: 18790317
BMJ Open. 2020 Dec 13;10(12):e040350
pubmed: 33318116
BMJ Glob Health. 2017 Jul 20;2(2):e000343
pubmed: 29225938
Int J Integr Care. 2015 Sep 23;15:e019
pubmed: 26528094
Int J Equity Health. 2019 Feb 28;18(1):38
pubmed: 30819193
Global Health. 2011 Nov 23;7:44
pubmed: 22112686
Health Aff (Millwood). 2017 Nov;36(11):1866-1875
pubmed: 29137514

Auteurs

Savina Chham (S)

National Institute of Public Health, Phnom Penh, Cambodia.
Centre for Population, Family and Health, Department of Social Sciences, University of Antwerp, Antwerp, Belgium.

Josefien Van Olmen (J)

Department of Family Medicine and Population Health (FAMPOP), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Wim Van Damme (W)

Department of Public Health, Institute of Tropical Medicine, Vrije Universiteit Brussel, Brussels, Belgium.
Department of Gerontology, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.

Srean Chhim (S)

National Institute of Public Health, Phnom Penh, Cambodia.

Veerle Buffel (V)

Centre for Population, Family and Health, Department of Social Sciences, University of Antwerp, Antwerp, Belgium.

Edwin Wouters (E)

Centre for Population, Family and Health, Department of Social Sciences, University of Antwerp, Antwerp, Belgium.
Centre for Health Systems Research and Development, University of the Free State, Bloemfontein, South Africa.

Por Ir (P)

National Institute of Public Health, Phnom Penh, Cambodia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH